Fiduciary Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Fiduciary Alliance's XBI Position: Q3 2026 in Review
Fiduciary Alliance increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.4% in Q3 2026, buying an estimated $814K and bringing the position to 59,844 shares worth $9.44M. The position accounts for 0.71% of the portfolio, ranked #29.
Fiduciary Alliance first reported a position in XBI in Q4 2022 and has held it in 16 quarters since. 959 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Fiduciary Alliance held 59,844 shares of State Street SPDR S&P Biotech ETF worth $9.44M as of Q3 2026.
- Fiduciary Alliance bought 5,153 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $814K.
- State Street SPDR S&P Biotech ETF made up 0.71% of Fiduciary Alliance's portfolio in Q3 2026, its #29 holding.
- Fiduciary Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 16 quarters since.
- 959 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.